1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News 06 OCTOBER 2014

Anti-Infective Drug News 06 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Gilead Acts To Secure Its Reign Over HIV-1 Market
Industry Brief - Vibativ Now Available In Europe For HAP/VAP
Industry Brief - FDA Grants Fast Track Designation For MEDI3902 In Nosocomial Pneumonia
Industry Brief - Salvat Reports Positive Phase III Results For Novel Otic Antibiotic/Steroid Solution
Industry Brief - Cempra Completes Enrolment In Solithromycin Phase III Trial For CABP
Industry Brief - Anacor's Kerydin Launched In US
Industry Brief - Cravit/Levofloxacin sNDA Submitted In Japan
Industry Trend Analysis - Novartis Backs Away From The Fierce Nature Of HCV Market
Industry Brief - Telavic Gains Japanese Approval For Additional Indication Of cHCV GT 2
Industry Brief - Ansun Reports Data On Clinical Activity Of ParaDase
Industry Brief - Novavax Initiates Phase II Trial Of RSV F Vaccine
Industry Brief - Sanofi Pasteur Launches Fluzone Quadrivalent Vaccine In Canada
Industry Brief - Flublok Now Available For 2014/15 Flu Season
Industry Brief - CHMP Issues Positive Opinion On Darunavir/Cobicistat FDC
Industry Brief - Veregen Marketing Authorisation Process Initiated For Eight Additional European Countries
Industry Trend Analysis - Third Class Of Flu Treatment Looming Despite Progressive Existing Drugs
Industry Brief - Gilead Submits NDA For LDV/SOF FDC In Japan
Industry Brief - Calixar/VirPath Develop Innovative Manufacturing Process For Flu Vaccines
Industry Brief - FDA Grants Expanded Access Use Of Tekmira's TKM-Ebola
Industry Brief - Janssen Responds To NICE Appraisal Consultation Document On Olysio
Industry Brief - MPP Enters TAF Sublicensing Agreements
Industry Brief - CHMP Adopts Positive Opinion On Gilead's Harvoni For cHCV
Industry Brief - Prezcobix Now Available In Canada For HIV
Industry Brief - SB-728-T Data Show Sustained Functional Control Of Viraemia In HIV-Infected Subjects
Industry Trend Analysis - Alios Acquisition Boosts J&J's HCV Combination Drug Capabilities
Industry Brief - Visterra Raises Funds To Advance Multiple Products Pipeline
Industry Brief - OnCore To Acquire Enantigen Therapeutics

Table Of Contents

Anti-Infective Drug News 06 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.